Karina Calzadilla | executive |
Chad Robins | executive |
Tycho Peterson | executive |
Daniel Brennan | analyst |
Susan Bobulsky | executive |
David Westenberg | analyst |
Mark Massaro | analyst |
Yuko Oku | analyst |
Andrew Brackmann | analyst |
Sharon Benzeno | executive |
Sung Ji Nam | analyst |
Elizabeth Webster | analyst |
Rachel Vatnsdal Olson | analyst |
Thank you for standing by, and welcome to the Adaptive Biotechnologies Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Karina Calzadilla, Head of Investor Relations. Please go ahead.
Thank you, Jonathan, and good afternoon, everyone.